Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 10/20 | 1.00 |
| ▸ | PPARG | P37231 | 8/20 | 1.00 |
| ▸ | F7 | P08709 | 7/20 | 1.00 |
| ▸ | F3 | P13726 | 7/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 6/20 | 1.00 |
| ▸ | PPARD | Q03181 | 6/20 | 1.00 |
| ▸ | PPARA | Q07869 | 6/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 5/20 | 1.00 |
| ▸ | OXER1 | Q8TDS5 | 4/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | RXRA | P19793 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | FFAR1 | O14842 | 5/20 | 0.85 |
| ▸ | MAPT | P10636 | 4/20 | 0.85 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.85 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.85 |
| ▸ | LMNA | P02545 | 3/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.85 |
| ▸ | HPGD | P15428 | 3/20 | 0.85 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Icosapent SCHEMBL18185487 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL1648318 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL12828369 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL1648015 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL2877002 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| SCHEMBL23417014 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185494 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18274961 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185412 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 | |
| Icosapent SCHEMBL18185423 | 1.00 | ALDH1A1 (1.00) | ALDH1A1PPARGF7F3CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250122219-A1 | BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF | GILEAD SCIENCES, INC. | 2025-04-17 | — | — | US | disclosed |
| US-20100317639-A1 | Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids | PETRONI ANNA | 2010-12-16 | — | — | US | disclosed |
| EP-1962856-B1 | MEDICAMENT BASED ON A MONOESTER OF STEROIDS WITH LONG CHAIN FATTY ACIDS | PETRONI ANNA (IT) | 2010-10-20 | — | — | EP | disclosed |
| US-20060147706-A1 | Sizing composition for glass staple fibres, method using said composition and resulting products | SAINT-GOBAIN VETROTEX FRANCE S.A. (FR) | 2006-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100317639-A1 | Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids | ACAT1, ACAT2, HSD17B12 | ALDH1A1 278/4885PPARG 96/4885F7 4304/4885 |
| US-20250122219-A1 | BRIDGED TRICYCLIC CARBAMOYLPYRIDONE COMPOUNDS AND USES THEREOF | SDHA, SDHB, DPYD | ALDH1A1 684/4885PPARG 1889/4885F7 2048/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.